TYRA · ISSUER CIK 1863127
Tyra Biosciences, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Tyra Biosciences, Inc. insiders reported $20K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Verjee Rehan (Director), with $20K.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$20KInsider buying
$0.00Insider selling
+$20KNet open-market
Sep 17, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 202619:29 | Sep 15, 2026 | TYRA | President and CEO, Director | A · Grant | $9.13 | +864 | 1,438,495 | +0% | $8K | ||
| Sep 17, 202619:26 | Sep 15, 2026 | TYRA | Vice President, Finance (PAO) | A · Grant | $9.13 | +2,925 | 11,258 | +35% | $27K | ||
| Sep 17, 202619:25 | Sep 15, 2026 | TYRA | Chief Financial Officer | A · Grant | $9.13 | +951 | 37,115 | +3% | $9K | ||
| Sep 11, 202616:30 | Sep 9, 2026 | TYRA | Director | P · Buy | $20.58 | +972 | 972 | New | +$20K | -37.8% | +4.4% |